Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 10 months
- Director since
- 2025
10 months of board service in total across 1 board, counting each seat separately. Longest: Cadrenal Therapeutics Inc., 10 months.
Cadrenal Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 2, 2026 | PTC Therapeutics Inc. | Open-market sale | −829 | $67.99 | $56,364 |
| Mar 5, 2026 | PTC Therapeutics Inc. | Open-market sale | −10,000 | $63.38 | $633,800 |
| Feb 18, 2026 | PTC Therapeutics Inc. | Open-market sale | −2,484 | $69.36 | $172,290 |
| Jan 8, 2026 | PTC Therapeutics Inc. | Open-market sale | −866 | $76.45 | $66,206 |
| Jan 7, 2026 | PTC Therapeutics Inc. | Open-market sale | −642 | $77.48 | $49,742 |
| Jan 6, 2026 | PTC Therapeutics Inc. | Open-market sale | −1,340 | $76.95 | $103,113 |
| Jan 2, 2026 | PTC Therapeutics Inc. | Grant or award | +18,750 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.